Sunny Pharmtech (6676.TWO) Stock Price

Sunny Pharmtech Price

CLOSED
6.21
​
Market closed

Revenue has compounded at 19.6% per year over the past 6 years to 418.01 M TWD. Sunny Pharmtech's net margin stands at -37.3%, down from -24.2% several years earlier.

Sunny Pharmtech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunny Pharmtech business model & stock analysis

Sunny Pharmtech Inc develops, manufactures, and markets generic and 505(b)2 drug products, primarily targeting the United States market. The company's main products include lectin drug complex (LDC) anesthesia analgesic ointment, neurofibrillary tangle (NFT) anti-urinary tract infection capsules, anti-mitochondrial antibody (AMA) hemostatic lozenges, cyclosporine A (CYA) injections for anemia, and campto (CPT) gynecological injections. These products are sold directly to customers in the United States, generating revenue through pharmaceutical sales. The company focuses on developing and commercializing specialized drug formulations, with its product portfolio centered on LDC, NFT, AMA, CYA, and CPT branded medications. Sales are concentrated in the United States, where the firm's generic and 505(b)2 drug products are marketed to healthcare providers and pharmacies. Revenue is derived from the direct sale of these pharmaceutical products to U.S. customers. Sunny Pharmtech Inc's business model relies on the development and marketing of its proprietary drug formulations, including LDC, NFT, AMA, CYA, and CPT products, which are sold to the United States market. The company's revenue stream is generated through the sale of these branded pharmaceutical products to U.S. healthcare institutions and retail pharmacies.

Frequently asked questions about Sunny Pharmtech

Converted at the current exchange rate, the Sunny Pharmtech share trades at 0.17 EUR (6.21 TWD).

The revenue cannot currently be calculated for Sunny Pharmtech.

The profit cannot currently be calculated for Sunny Pharmtech.

The P/E ratio cannot be calculated for Sunny Pharmtech at the moment.

The P/S cannot be calculated for Sunny Pharmtech currently.

The Eulerpool Quality Score for Sunny Pharmtech is 4/10.

The ISIN of Sunny Pharmtech is TW0006676000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sunny Pharmtech is 6676.TWO. The ticker symbol is used to trade Sunny Pharmtech shares on the stock exchange.

Fair ValueTerminal
6.46 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
3.40 M TWD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jan 19, 2022
ISIN
TW0006676000
Cusip
Y8T416102
Market capitalization
929.51 M TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.89
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-10.89 %
Last updated Nov 22, 2026, 3:45 AM

Sunny Pharmtech Peer Group

Sunny Pharmtech FIGI

6676:TT (Taipei Stock Exchange) · BBG014HDM482